This content is machine translated Chronic spontaneous urticaria When antihistamines are not enough – ligelizumab soon available in addition to omalizumab? The biologic omalizumab has empirically well-documented efficacy and safety and is considered the treatment of choice in international guidelines for cases of chronic spontaneous urticaria with inadequate response to antihistamines.…
View Post 4 min This content is machine translated Update in urticaria Finally, more news on urticaria management Things are happening again in the field of urticaria management. Classification as well as treatment recommendations have been updated and new insights have been gained in causal research, which may…
